Notice Pursuant to the National Cooperative Research and Production Act of 1993-Medical CBRN Defense Consortium, 20521 [2021-08078]

Download as PDF Federal Register / Vol. 86, No. 74 / Tuesday, April 20, 2021 / Notices Register pursuant to Section 6(b) of the Act on January 19, 2021 (86 FR 5250). DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Countering Weapons of Mass Destruction Notice is hereby given that, on March 26, 2021, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Countering Weapons of Mass Destruction Consortium (‘‘CWMD’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Applied Technology, Inc., King George, VA; CDO Technologies, Inc., Dayton, MD; Kestrel Corporation, Albuquerque, NM; Marcon Engineering, Inc., Escondido, CA; Matsys, Inc., Sterling, VA; MZA Associates Corporation, Albuquerque, NM; OptoKnowledge, Torrance, CA; Rensselaer Polytechnic Institute, Troy, NY and SafetySpect, Inc., Los Angeles, CA have been added as parties to this venture. Also, California Institute of Technology, Pasadena, CA; Defense Equipment Company, Alpharetta, GA; Efiia Consulting LLC, Falls Church, VA; HII Mission Driven Innovative Solutions, Huntsville, AL; Immersive Wisdom, Inc., Boca Raton, FL; Mobilestack, Inc., Dublin, CA; Newton Services LLC; Cody, WY and TRX Systems, Inc., Greenbelt, MD have withdrawn from this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and CWMD intends to file additional written notifications disclosing all changes in membership. On January 31, 2018, CWMD filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on March 12, 2018 (83 FR 10750). The last notification was filed with the Department on January 7, 2021. A notice was published in the Federal VerDate Sep<11>2014 17:10 Apr 19, 2021 Jkt 253001 Suzanne Morris, Chief, Premerger and Division Statistics, Antitrust Division. [FR Doc. 2021–08077 Filed 4–19–21; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Medical CBRN Defense Consortium Notice is hereby given that, on March 29, 2021, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Medical CBRN Defense Consortium (‘‘MCDC’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, AAG Associates LLC, Pocasset, MA; Arrevus, Inc., Raleigh, NC; Chemring Sensors & Electronic Systems, Inc., Charlotte, NC; Federal Resources Supply Company, Stevensville, MD; Genovac Antibody Discovery, Fargo, ND; Hager Biosciences LLC, Bethlehem, PA; Healion Bio, Inc., Ijamsville, MD; Immunome, Inc., Exton, PA; Invenra, Inc., Madison, WI; Optoknowledge, Torrance, CA; Sanaria, Inc., Rockville, MD; Tao Treasures dba Nanobiofab, Frederick, MD; TFF Pharmaceuticals, Inc., Austin, TX; The University of Nebraska at Omaha, Omaha, NE; The University of California Los Angeles, Los Angeles, CA and Tiber Creek Partners LLC, Oakton, VA have been added as parties to this venture. Also, Abiogenix, Inc., Rochester, MI; Blade Therapeutics, Inc., South San Francisco, CA; South San Francisco, CA; Bluejay Diagnostics, Inc., Acton, MA; Claremont Biosolutions LLC, Upland, CA; Decisive Point LLC, Alexandria, VA; Efiia Consulting LLC, Falls Church, VA; Equillium, Inc., La Jolla, CA; GenScript USA, Inc.; LDS Technology Consultants, Inc., Warwick, PA; Lillian Bay Holdings LLC, Saint Petersburg, FL; Massachusetts Eye and Ear Infirmary, Boston, MA; PhaseBio Pharmaceuticals, Inc., Malvern, PA; Planet Biotechnology, Inc., Hayward, CA; Shift Labs, Inc., Seattle, WA; The University of California San Diego, La PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 20521 Jolla, CA; ThermoAnalytics, Inc., Calumet, MI and United National Native Council, Payson, AZ have withdrawn as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and MCDC intends to file additional written notifications disclosing all changes in membership. On November 13, 2015, MCDC filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on January 6, 2016 (81 FR 513). The last notification was filed with the Department on January 08, 2021. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on January 19, 2021 (86 FR 5250). Suzanne Morris, Chief, Premerger and Division Statistics, Antitrust Division. [FR Doc. 2021–08078 Filed 4–19–21; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Digital Manufacturing Design Innovation Institute Notice is hereby given that, on March 31, 2021, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Digital Manufacturing Design Innovation Institute (‘‘DMDII’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, the following parties have joined DMDII: Rich Brilliant Willing, Brooklyn, NY; University of North Carolina—Charlotte, Charlotte, NC; Cook County Government, Chicago, IL; The University of West Florida, Pensacola, FL; University of Pittsburgh, Pittsburgh, PA; Factory Scene, Pittsburgh, PA; Pashi, San Francisco, CA; 6clicks, Washington, DC; MPDV USA, Inc., Orland Park, IL; BreakPoint Labs, Falls Church, VA; The Intelligence Factory, Kirkwood, MO; SVA Illinois, Chicago, E:\FR\FM\20APN1.SGM 20APN1

Agencies

[Federal Register Volume 86, Number 74 (Tuesday, April 20, 2021)]
[Notices]
[Page 20521]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-08078]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Medical CBRN Defense Consortium

    Notice is hereby given that, on March 29, 2021, pursuant to Section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (``the Act''), Medical CBRN Defense Consortium 
(``MCDC'') has filed written notifications simultaneously with the 
Attorney General and the Federal Trade Commission disclosing changes in 
its membership. The notifications were filed for the purpose of 
extending the Act's provisions limiting the recovery of antitrust 
plaintiffs to actual damages under specified circumstances. 
Specifically, AAG Associates LLC, Pocasset, MA; Arrevus, Inc., Raleigh, 
NC; Chemring Sensors & Electronic Systems, Inc., Charlotte, NC; Federal 
Resources Supply Company, Stevensville, MD; Genovac Antibody Discovery, 
Fargo, ND; Hager Biosciences LLC, Bethlehem, PA; Healion Bio, Inc., 
Ijamsville, MD; Immunome, Inc., Exton, PA; Invenra, Inc., Madison, WI; 
Optoknowledge, Torrance, CA; Sanaria, Inc., Rockville, MD; Tao 
Treasures dba Nanobiofab, Frederick, MD; TFF Pharmaceuticals, Inc., 
Austin, TX; The University of Nebraska at Omaha, Omaha, NE; The 
University of California Los Angeles, Los Angeles, CA and Tiber Creek 
Partners LLC, Oakton, VA have been added as parties to this venture.
    Also, Abiogenix, Inc., Rochester, MI; Blade Therapeutics, Inc., 
South San Francisco, CA; South San Francisco, CA; Bluejay Diagnostics, 
Inc., Acton, MA; Claremont Biosolutions LLC, Upland, CA; Decisive Point 
LLC, Alexandria, VA; Efiia Consulting LLC, Falls Church, VA; Equillium, 
Inc., La Jolla, CA; GenScript USA, Inc.; LDS Technology Consultants, 
Inc., Warwick, PA; Lillian Bay Holdings LLC, Saint Petersburg, FL; 
Massachusetts Eye and Ear Infirmary, Boston, MA; PhaseBio 
Pharmaceuticals, Inc., Malvern, PA; Planet Biotechnology, Inc., 
Hayward, CA; Shift Labs, Inc., Seattle, WA; The University of 
California San Diego, La Jolla, CA; ThermoAnalytics, Inc., Calumet, MI 
and United National Native Council, Payson, AZ have withdrawn as 
parties to this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and MCDC intends to file additional 
written notifications disclosing all changes in membership.
    On November 13, 2015, MCDC filed its original notification pursuant 
to Section 6(a) of the Act. The Department of Justice published a 
notice in the Federal Register pursuant to Section 6(b) of the Act on 
January 6, 2016 (81 FR 513).
    The last notification was filed with the Department on January 08, 
2021. A notice was published in the Federal Register pursuant to 
Section 6(b) of the Act on January 19, 2021 (86 FR 5250).

Suzanne Morris,
Chief, Premerger and Division Statistics, Antitrust Division.
[FR Doc. 2021-08078 Filed 4-19-21; 8:45 am]
BILLING CODE P